Mnk kinase pathway: Cellular functions and biological outcomes
about
Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies.Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer.Clinical and Molecular Assessment in a Female with Fragile X Syndrome and Tuberous Sclerosis.Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer.Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers.Dysregulation of the MEK/ERK/MNK1 signalling cascade by middle T antigen of the trichoydsplasia spinulosa polyomavirus.Hippocampal metabotropic glutamate receptor long-term depression in health and disease: focus on mitogen-activated protein kinase pathways.AMP-activated Protein Kinase Up-regulates Mitogen-activated Protein (MAP) Kinase-interacting Serine/Threonine Kinase 1a-dependent Phosphorylation of Eukaryotic Translation Initiation Factor 4E.The immunomodulatory effects of barettin and involvement of the kinases CAMK1α and RIPK2.New synthetic AICAR derivatives with enhanced AMPK and ACC activation.Sulfoximine substituted quinazolines for pharmaceutical compositions US 20150005278 (A1): a patent evaluation.5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.The eukaryotic translation initiation factor eIF4E wears a "cap" for many occasions.BDNF stimulation of protein synthesis in cortical neurons requires the MAP kinase-interacting kinase MNK1.MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer.Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials.Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.Loss of eIF4E phosphorylation engenders depression-like behaviors via selective mRNA translation.Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells.Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils.A whole-animal platform to advance a clinical kinase inhibitor into new disease space.Synergistic effects of inhibiting the MNK-eIF4E and PI3K/AKT/ mTOR pathways on cell migration in MDA-MB-231 cells.Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication.Translation acrobatics: how cancer cells exploit alternate modes of translational initiation
P2860
Q35653810-455F4E61-3878-410F-AE56-5C2E98B330EDQ36214081-467819D4-40E1-4185-88F6-7AC709D14755Q36573991-AE024DEC-55C2-4775-BF55-9C7220D49E84Q37582210-719CC743-DED1-40C5-B272-0E93A48C1493Q37656557-9F87E2E2-DACB-4043-BCFC-E7F1A841FCF6Q38514906-CD6FD6B4-B465-49FF-B67D-9DBC732401C6Q38637354-36632018-0DC5-4198-AC89-63B762B26440Q38703630-46261F62-3F52-483E-9818-6445ED75B4DEQ38753843-1762AE9C-9634-4316-826F-ACBCF5AFF6CEQ38758276-7D1CCB55-E4DA-494C-9233-9F60C5F8CC6DQ38827955-C6216991-BEA7-4609-B53B-702D82550DEBQ38829598-9136AEAE-EEBF-4DBB-A4CE-5CCDD85A5CD1Q38871487-935DF727-7268-440F-9145-D71FCB37469CQ38912901-C42E50C2-4EB0-488F-A396-1B169DD37A06Q39326047-76697573-6407-4F1B-A5EC-524E7E54510DQ39549442-243E698D-63D6-40B3-9733-F895A11106BAQ41546726-900B8AC0-46CB-410D-B7E4-73B268CF2008Q41636936-14574165-CF6A-4D2D-8351-5C89EDA80F10Q46713797-44DAA9D0-2809-41E8-96F1-2EC34D524430Q47435333-F6CC4F11-2B5B-425E-9D69-0A6AEC4348BBQ47647133-E69092D5-BD7A-4A94-A1D7-7FD3BD2153D4Q47830442-99F51182-77CB-47C1-A3C6-7531687896B5Q49790269-C59D3B06-9D31-4CF1-86D7-F1320070F9EDQ49884409-55E51A83-84E1-4370-BAF8-6D71DB60D516Q52340912-B99D5132-DBD3-49E8-89BE-FAFA09308E06Q54116240-9D65E48B-3F0C-4BEB-ADB9-878B48F0259AQ58374805-6CFA4F29-62E7-470D-A956-DC09FE8CD342
P2860
Mnk kinase pathway: Cellular functions and biological outcomes
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mnk kinase pathway: Cellular functions and biological outcomes
@ast
Mnk kinase pathway: Cellular functions and biological outcomes
@en
Mnk kinase pathway: Cellular functions and biological outcomes
@nl
type
label
Mnk kinase pathway: Cellular functions and biological outcomes
@ast
Mnk kinase pathway: Cellular functions and biological outcomes
@en
Mnk kinase pathway: Cellular functions and biological outcomes
@nl
prefLabel
Mnk kinase pathway: Cellular functions and biological outcomes
@ast
Mnk kinase pathway: Cellular functions and biological outcomes
@en
Mnk kinase pathway: Cellular functions and biological outcomes
@nl
P2860
P3181
P356
P1476
Mnk kinase pathway: Cellular functions and biological outcomes
@en
P2093
Sonali Joshi
P2860
P304
P3181
P356
10.4331/WJBC.V5.I3.321
P407
P577
2014-08-26T00:00:00Z